Delivery Order SPE2DB24D2212-SPE2DB25FHQMX
- Not listed
- The Defense Logistics Agency awarded a $5,066.04 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of 90 tablets of Jardiance 25 mg, a diabetes medication. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without set-aside designation. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $7,691.02 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $24,339.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to the prime contractor. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $35,131.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a direct supply of the diabetes medication to support federal medical procurement needs. The contract was competitively awarded with no set-aside designation, and performance will be executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jardiance 25 mg tablets in a 90-count package. This firm fixed-price delivery order, valued at $106,293.56, is scheduled for completion by August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a $7,108.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded without set-aside designation and has an ultimate completion date of August 11, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a $13,432.45 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a diabetes medication. The contract, executed on July 23, 2025, with an ultimate completion date of July 24, 2025, utilizes firm fixed pricing under a non-competitive set-aside delivery order structure. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order functions as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract valued at $23,977.17. The delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 18, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $23,977.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQMXDelivery Order
The Defense Logistics Agency awarded a $25,980.72 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 90-count tablets of Jardiance 25 mg, a medication used in diabetes management. The contract is structured as a firm fixed-price delivery order with a completion date of August 13, 2025, and carries no set-aside designation, indicating it was awarded through open competition. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen serves as a prime pharmaceutical vendor for federal military and healthcare systems, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The parent IDC supports Defense Health Agency, U.S. Coast Guard, and other government healthcare entities worldwide, providing flexible access to pharmaceutical commodities essential for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.0k | 8/12/25 |